000			02033 a2200589 4500
005			20250517134932.0
264		0	_c20170516
008			201705s 0 0 eng d
022			_a1090-2430
024	7		_a10.1016/j.expneurol.2017.01.012 _2doi
040			_aNLM _beng _cNLM
100	1		_aFrau, Roberto
245	0	0	_aThe 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease. _h[electronic resource]
260			_bExperimental neurology _c05 2017
300			_a1-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a5-alpha Reductase Inhibitors _xtherapeutic use
650	0	4	_aAdrenergic Agents _xtoxicity
650	0	4	_aAnimals
650	0	4	_aAntiparkinson Agents _xadverse effects
650	0	4	_aBenserazide _xadverse effects
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDyskinesia, Drug-Induced _xdrug therapy
650	0	4	_aFemale
650	0	4	_aFinasteride _xtherapeutic use
650	0	4	_aFunctional Laterality _xdrug effects
650	0	4	_aLevodopa _xadverse effects
650	0	4	_aMale
650	0	4	_aOxidopamine _xtoxicity
650	0	4	_aParkinson Disease _xdrug therapy
650	0	4	_aPsychomotor Disorders _xchemically induced
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aTime Factors
650	0	4	_aTyrosine 3-Monooxygenase _xmetabolism
700	1		_aSavoia, Paola
700	1		_aFanni, Silvia
700	1		_aFiorentini, Chiara
700	1		_aFidalgo, Camino
700	1		_aTronci, Elisabetta
700	1		_aStancampiano, Roberto
700	1		_aMeloni, Mario
700	1		_aCannas, Antonino
700	1		_aMarrosu, Francesco
700	1		_aBortolato, Marco
700	1		_aDevoto, Paola
700	1		_aMissale, Cristina
700	1		_aCarta, Manolo
773	0		_tExperimental neurology _gvol. 291 _gp. 1-7
856	4	0	_uhttps://doi.org/10.1016/j.expneurol.2017.01.012 _zAvailable from publisher's website
999			_c26827006 _d26827006